Navigation Links
Chilean President's Cousin Successfully Tests Allergy 'Knockout' Technique on Mice

on with serious consequences.

With a view to overcome this problem, Bachelet and his research colleague Ariel Munitz have designed a small, synthetic, antibody fragment that has the unusual ability of recognizing two targets simultaneously-the receptor CD300a and a mast cell-specific marker. This makes the antibody targets CD300a only on the surface of mast cells, avoiding suppression of other immune cells.

During the study, this antibody potently eliminated four different types of allergic diseases in mice. The researchers also noted that upon administration of the antibody in nose drops, mice suffering from sever chronic asthma completely reverted to normal in less than two months.

Termed RECEPTRA, the pioneering project presents a novel therapeutic strategy for acute and chronic allergic diseases, and is currently being licensed through Yissum, the Hebrew University's technology transfer company, to pharmaceutical companies for further development and eventual clinical trials.

Bachelet predicts that with further development, his technology may become the first line of allergy therapy in the near future.


'"/>




Page: 1 2

Related medicine news :

1. Former Chilean Dictator Hospitalised After Heart Attack
2. Former Chilean Dictator Recovering
3. Chicken Dishes Were Off The Menu At Pakistan Presidents House
4. Reserved category doctors seek Presidents intervention
5. US Senate Approves Embryo-research Plan Despite Presidents Refusal
6. Cipro Has Cheaper Cousins to Treat Anthrax
7. Fruitfly My Distant Cousin
8. Cousins Recovering from His Substance Abuse Problem
9. Cousins Recovering from His Substance Abuse Problem
10. French Doctors Successfully Separate Twins Joined At Spine
11. Alzheimer’s disease trial With EVT 101 For Successfully Complete
Post Your Comments:
(Date:12/4/2009)...Newswire/ -- Thousands of KPMG LLP employees came ... to participate in a community service event which...rt for literacy with charitable giving. ,, "Th...istory of volunteerism. Instead of holiday parties...o brighten the holidays for some children," said T...
(Date:12/4/2009).... 4 Healthcare Trust of America, I...te investment trust, announced the execution of a ...lding medical office portfolio located in San Ange...na for approximately $20,500,000. The closing of ...a number of conditions. ,, The approximately 92...
(Date:12/4/2009)...PRNewswire-USNewswire/ -- While Congress debates w...e costs, Leapfrog,s purchaser members point to 45 ...the best quality care in the nation while attainin...ban, eight children,s and three rural hospitals ha...n results from The Leapfrog Hospital Survey. ,...
(Date:12/4/2009)...at Johns Hopkins publishing in the December issue ... gene called "Twist" may be the proverbial red fla...drive aggressive, metastatic breast cancer from ot...rk suggesting that it is a relatively rare subgrou...t cancer, scientists have surmised that this subgr...
(Date:12/4/2009)...ourism is a phenomenon that was started by people ...rice of dental work in the US, Canada, and other c...care, people have found that Mexican Dental Vacati...on. , (PRWEB) December 4,...ears, Mexican Dental Vacation is seeing their best...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...ient, Inc.,(Nasdaq: CLRT ), a premier technology ...s and the pharmaceutical industry, today announced...County Technology Fast 50.,In addition, Clarient w...technology, media, telecommunications and life sci...
... Virus Today; Disease Endemic in ...ofi Pasteur, the,vaccines division of sanofi-avent...clusive global collaboration agreement with Acambi...tists,believe that a safe and effective vaccine ma...
... PET scans can help clinicians diagnose and treat ...imaging technology helps people with cancer live l...nsive review by the U.K. National Health Service. ...g technologies such as computerized tomography (CT...
...inary levels of certain molecules might have the p...life-shortening kidney ailment caused by the autoi...r researchers have found. , Our studies suggest a...available online at the Journal of Immunology. G...
...s born just,a few weeks premature are six times mo...han full-term babies, according to an analysis pub...own from previous studies that late preterm infant... and,brain development, Now we have evidence that ...
... Nov. 12 /PRNewswire-FirstCall/ - Cardiome Pharma ...at it will report 2007 third,quarter financial res...7.,Cardiome will hold a teleconference call and we...-540-8136. There will be a separate dial-in line f...
Other Medicine News:Health News:Clarient Named to Deloitte's 2007 Orange County Technology Fast 50 for Third Consecutive Year 2Health News:Clarient Named to Deloitte's 2007 Orange County Technology Fast 50 for Third Consecutive Year 3Health News:Clarient Named to Deloitte's 2007 Orange County Technology Fast 50 for Third Consecutive Year 4Health News:Clarient Named to Deloitte's 2007 Orange County Technology Fast 50 for Third Consecutive Year 5Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 2Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 3Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 4Health News:PET scans useful for some cancer treatment, but how do patients fare? 2Health News:Researchers investigate ways to detect lupus-associated kidney disease 2Health News:Higher Risk of Death for Babies Born Just a Few Weeks Early, Study Finds 2Health News:Cardiome To Release Third Quarter Results 2Health News:Cardiome To Release Third Quarter Results 3
(Date:12/4/2009)... ,, WASHINGTON, Dec. 4 /PRNewswire-USNewsw...ew report published by the Pharmaceutical Resea...dentifies 97 new drugs and vaccines in development... report found that the 97 products in developmen...gs are either in human clinical trials or awaiting...
(Date:12/4/2009)..., BILLERICA, Mass., Dec. 4 /PRNewswire-FirstCall/...diary of Volcano Corporation (Nasdaq: VOLC ), tod...l testing of a novel integrated light source archi...rietary optical engine design raises the bar on im...of laser-based designs for swept source OCT light ...
(Date:12/4/2009)...THESDA, Md., Dec. 4 Nort...y") (OTC Bulletin Board: NWBO) announced today tha...ts patent application on a system for automation o...pany,s DCVax® therapeutic cancer vaccines. T...ery high concentration of dendritic cells (which a...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5DUSA Pharmaceuticals Inc 28R 29 Announces Second Quarter Financial Results and Corporate Highlights Conference Call 53811 1Coastal Contacts Helps Students Set Sights on Good Grades with 2419 95 Glasses 53809 1Coastal Contacts Helps Students Set Sights on Good Grades with 2419 95 Glasses 53809 2Lexi Comp ONLINE 26amp 3B 238482 3B for Oral Surgery 53806 1Lexi Comp ONLINE 26amp 3B 238482 3B for Oral Surgery 53806 2Lexi Comp ONLINE 26amp 3B 238482 3B for Oral Surgery 53806 3
... Continue to Highlight Potential of NeoVista,s ...TTSDALE, Ariz., Sept. 29 NeoVista, Inc. made publ...e II feasibility study,examining its novel epireti... age-related macular degeneration (AMD) at the 41s...ng-term data from the study, which was initiated,t...
...kembe Mutombo Foundation to improve healthcare,sys...YORK, Sept. 25 The Clinton Global,Initiative reco...BDX ), a,leading global medical technology company...tion (DMF) to enhance immune system monitoring and...mbo Hospital (BMMH) and,Research Center in the Dem...
Other Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
Surgiflex® WAVE XP™ Handpiece and Pump, without probe shaft
Surgiflex® WAVE XP™ Handpiece and Pump
SUCTION IRRIGATION: StrykeFlow PS
SUCTION IRRIGATION: StrykeFlow 2
Medicine Products: